Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that the Japanese division of its subsidiary Kannaway® had its best revenue month ever in Company history in July 2020.
“The hemp-derived cannabidiol (CBD) market in Asia has exploded over the past year and, despite a global pandemic, this market continues to gain new consumers who are eager to take part,”
said Medical Marijuana, Inc. CEO Dr. Stuart Titus.
“We are proud to be one of the pioneers in bringing CBD to Japan and look forward to accomplishing many more financial and operational milestones in this country and other Asian countries in the near future.”
China and Japan present a large opportunity for Kannaway® as, according to Prohibition Partners, they collectively account for about 90 percent of Asia’s CBD market. The CBD market in Asia is projected to be worth $5.8 billion by 2024.
“We are excited about our growth in Japan and look forward to continuing to develop the marketplace,”
said Kannaway® CEO Blake Schroeder.
Kannaway® is a network sales and marketing company specializing in the sales and marketing of hemp-based botanical products. Kannaway® currently hosts weekly online sales meetings and conferences across the United States, offering unique insight and opportunity to sales professionals who are desirous of becoming successful leaders in the sale and marketing of hemp-based botanical products.
About Medical Marijuana, Inc.
We are a company of firsts®. Medical Marijuana, Inc. (MJNA) is a cannabis company with three distinct business units in the non-psychoactive cannabinoid space: a global portfolio of cannabinoid-based nutraceutical brands led by Kannaway® and HempMeds®; a pioneer in sourcing the highest-quality legal non-psychoactive cannabis products derived from industrial hemp; and a cannabinoid-based clinical research and botanical drug development sector led by its pharmaceutical investment companies and partners including AXIM® Biotechnologies, Inc. and Kannalife, Inc. Medical Marijuana, Inc. was named a top CBD producer by CNBC. Medical Marijuana, Inc. was also the first company to receive historic import permits for CBD products from the governments of Brazil, Mexico, Argentina, and Paraguay and is a leader in the development of international markets. The company’s flagship product Real Scientific Hemp Oil has been used in several successful clinical studies throughout Mexico and Brazil to understand its safety and efficacy.
Medical Marijuana, Inc.’s headquarters is in San Diego, California, and additional information is available at OTCMarkets.com or by visiting www.medicalmarijuanainc.com. To see Medical Marijuana, Inc.’s corporate video, click here.
Get more information, facts and figures about Kannaway, click here for the Kannaway overview.